Descriptions of NTP Study Types
Abstract for Immunotoxicity Study of Isoniazid
The Immunotoxicity of Isoniazid (CAS No. 54-85-3) in Female B6C3F1 Mice
NTP Report Number IMM96002
Summary
Isonicotinic acid hydrazide (INH, Isoniazid), an analogue of pyrodoxine
(vitamin B6), is a white crystalline solid that is
moderately soluble in water and slightly soluble in alcohol and
chloroform. INH is practically insoluble in ether and benzene.
INH is a first-line antimycobacterial agent in the treatment of
tuberculosis where the infecting agent is Mycobacterium tuberculosis
or Mycobacterium kansasii.
Isonicotinic acid hydrazide (INH) was nominated to the NTP for
toxicological evaluation and was selected for immunotoxicity studies
by the chemical manager. Thus, the purpose of these studies was
to determine the effect of INH on the immune system.
The studies were conducted in female B6C3F1
mice. The animals were administered isonicotinic acid hydrazide
daily for 14 days at doses of 25, 50 and 100 mg/kg by oral gavage.
In some of the studies, an additional 150 mg/kg dose group was
added to better characterize the dose-response relationship for
the assay. In all studies, isonicotinic acid hydrazide was prepared
as a solution in deionized water.
The baseline toxicology studies are summarized in Table ES-1.
Daily oral administration of INH to female B6C3F1
mice for 14 days at 25, 50 and 100 mg/kg (and 150 mg/kg for a
standard toxicity evaluation) did not affect body weight gain/loss
nor was any organ gross pathology observed. There was a modest
increase in liver and kidney weight in animals exposed to 150
mg/kg and a small, but significant, increase in spleen weight
in the 100 mg/kg group only. Hematology was unremarkable.
Table ES-2 summarizes the immunology studies.
B cell and T cell numbers including T cell subsets were not altered
by INH. Serum titers of IgM anti-sRBC were decreased 33% in animals
given 100 mg/kg INH and the results of trend analysis were positive.
INH exposure for 14 days did not alter spleen IgM antibody-forming
cell activity. The mixed leukocyte response was essentially normal.
Cytotoxic T cell activity appeared to be stimulated at 25 and
50 mg/kg, but no effect was detected at 100 mg/kg. Natural killer
cell activity remained normal at all INH dose levels nor was the
functional activity of the reticuloendothelial system affected.
The results of the host resistance studies are summarized in Table ES-3.
INH had essentially no effect in the B16F10 melanoma and Listeria
monocytogenes host resistance assays. However, INH at 100
mg/kg did tend to afford some protection in the Streptococcus
pneumoniae host resistance assay.
Overall, at relatively high exposure levels, INH may adversely
affect the antibody cell response while stimulating cytotoxic
T cell activity.
Table ES-1
SUMMARY TABLE FOR TOXICOLOGY STUDIES
INH-14-1-PO
| |||||||
Parameter | Result | Maximum Effect | Dose | Comment | |||
---|---|---|---|---|---|---|---|
| |||||||
Body Weight | |||||||
Day 8 | No Effect | ||||||
Day 15 | No Effect | ||||||
Weight Changes | |||||||
Day 8-1 | No Effect | ||||||
Day 15-1 | No Effect | ||||||
| |||||||
Pathology | |||||||
Gross Pathology | No Effect | ||||||
Histopathology | Not Done | ||||||
Organ Weights | |||||||
Liver | Increased | 18% | 150 mg/kg | ||||
Spleen | Increased | 21% | 100 mg/kg | ||||
Lungs | No Effect | ||||||
Thymus | No Effect | ||||||
Kidney | Increased | 8% | 150 mg/kg | % Body Wt |
|||
| |||||||
Hematology | |||||||
RBCs | No Effect | ||||||
Hemoglobin | No Effect | ||||||
Hematocrit | No Effect | ||||||
MCV | No Effect | ||||||
MCH | No Effect | ||||||
MCHC | Increased | 1% | 100 mg/kg | ||||
Reticulocytes | No Effect | ||||||
Leukocytes | No Effect | ||||||
Leukocyte Diff | |||||||
Lymphocytes | No Effect | ||||||
Neutrophils | No Effect | ||||||
Eosinophils | No Effect |
Table ES-2
SUMMARY TABLE FOR IMMUNOLOGY STUDIES
INH-14-1-PO
| ||||
Parameter | Results | Maximum Effect | Dose | Comment |
---|---|---|---|---|
| ||||
Surface Markers | ||||
Ig+ | No Effect | |||
CD3+ | No Effect | |||
CD4+CD8- | No Effect | |||
CD4-CD8+ | No Effect | |||
CD4+CD8+ | No Effect | |||
| ||||
IgM Humoral Immune Response to Sheep Erythrocytes | ||||
Spleen IgM AFC to sRBC | No Effect | |||
Serum Titers to sRBC | Decreased | -33% | 100 mg/kg | |
| ||||
Proliferation Assay, Mixed Leukocyte Response | ||||
MLR | Decreased | -15% | 50 mg/kg | |
| ||||
Cytotoxic T Lymphocyte Activity | ||||
CTL | Increased | 57% | 50 mg/kg | 0.75/1 E:T Ratio |
| ||||
Functional Activity of the Reticuloendothelial System | ||||
RES | No Effect | |||
| ||||
NK Cell Activity | ||||
1:100 | No Effect | |||
1:50 | No Effect | |||
1:25 | No Effect | |||
|
Table ES-3
SUMMARY TABLE FOR HOST RESISTANCE STUDIES
INH-14-1-PO
| ||||
Parameter | Results | Maximum Effect | Dose | Comment |
---|---|---|---|---|
| ||||
Listeria monocytogenes | No Effect | |||
Streptococcus pneumoniae | No Effect | |||
B16F10 Melanoma | No Effect | |||
|
Report Date: November 1995
Web page last updated on February 21, 2005